Elastomeric Infusion Pumps Market
                     Elastomeric Infusion Pumps Market- Size, Share, Outlook, and Opportunity 
Analysis, 2020- 2027
Elastomeric infusion pumps, also known as disposable balloon pumps, are used 
to administer IV drugs such as local anesthetics, antibiotics, and anti-neoplastics.
These non-electronic, non-gravity driven devices are used in single infusions. 
Elastomeric infusion pumps contain a stretchable balloon reservoir that is filled 
with a drug and pressure from the elastic walls drives fluid delivery with relatively 
consistent pressure until it reaches near the end of the infusion.The global 
elastomeric infusion pumps market is estimated to account for US$ 1,595.0 Mn in
terms of value by the end of 2027
Request a sample copy of this report:- 
https://www.coherentmarketinsights.com/insight/request-sample/3129 
Post-operative pain in surgeries such as total  knee replacement and total hip
replacement  is  usually  treated  by  infusion  of  analgesics  through  disposable
infusion  pumps.  Therefore,  increasing  number  of  orthopedic  procedures  and
surgeries is expected to boost growth of the global elastomeric infusion pumps
market  over  the  forecast  period.  For  instance,  The  2018  Annual  Report  of
American Academy of Orthopedic Surgeons, over 1 million patients and over 1.4
million hip  and knee arthroplasty  procedures were entered into  the American
Joint Replacement Registry.
Moreover, elastomeric infusion pumps are cheaper and have fewer adverse 
effects compared to electronic pumps, which increases their adoption in 
ambulatory chemotherapy infusion centers. Moreover, as elastomeric infusion 
pumps do not require electricity to operate, the risk for free flow of medication to 
patients is eliminated. Such advantages of elastomeric infusion pumps over their 
electric counterparts is also expected to boost growth of the market.  
North America region held dominant position in the global elastomeric infusion 
pumps market in 2018, accounting for 33.0% share in terms of value, followed by
Asia Pacific.The costs of elastomeric infusion pumps keeps fluctuating 
depending on the type of the pumps. For instance, the cost of pumps 
administering antibiotics is significantly low, whereas the cost of pumps 
administering pain management drugs is relatively high and ranges between US$
160 and US$ 450. Such scenario is expected to hinder growth of the global 
elastomeric infusion pumps market over the forecast period.
Moreover, stringent regulations regarding the use of plastics in elastomeric 
infusion pumps is also expected to hamper the market growth. For instance, the 
European Commission and the U.S. FDA published a safety assessments of 
medical devices containing Di (2-ethylhexyl) phthalate (DEHP) and plasticized 
polyvinylchloride (PVC) in parts of elastomeric infusion pumps. Therefore, 
manufacturers need to focus on for proper safety labeling of products to avoid 
severe side effects, especially in neonatal patient population.
Elastomeric infusion pumps can be used in portable regional anesthesia. Several
studies have also demonstrated that the use of elastomeric infusion device 
following shoulder surgery allows safe and early discharge of patients with 
decreased need for parenteral opiate analgesia. Moreover, use of elastomeric 
infusion pumps in portable regional anesthesia is increasing in ambulatory care 
centers, dental care units, and cancer care centers the U.S., which is expected to
offer lucrative growth opportunities for market players.
Moreover, increasing adoption of elastomeric infusion pumps in administration of 
chemotherapy drugs at ambulatory care centers and home care setting is also 
expected to offer significant growth opportunities for market players. 
Key players in the market need to focus on effects of temperature, fill volume, 
and diluent on flow rates in elastomeric infusion pumps. Proper labelling of flow 
rates and monitoring of models as per desired infusion time is also important 
while production of the infusion pumps.
Key players in the market are focused on integrating elastomeric infusion pumps 
with other digital technologies. For instance, in April 2017, B. Braun Medical Inc. 
integrated its Easypump ST/LT Elastomeric Infusion Pump System with an 
innovative app that offers educational content to clinicians and patients on the 
safe use and features of the Easypump for short- and long-term home infusion 
therapy.Major players operating in the global elastomeric infusion pumps market 
include, B. Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, 
Baxter International Inc., Halyard Health, and Nipro Corporation.
Get the main link:-  https://www.coherentmarketinsights.com/market-insight/elastomeric-
infusion-pumps-market-3129 
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Visit our news Website: http://www.coherentchronicle.com/